Bruker Cellular Analysis, Inc. financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q2 2023.

Location
Emeryville, CA
Fiscal year end
31 December
Latest financial report
14 Aug 2023

Shareable Research Card

Bruker Cellular Analysis, Inc. Financial Facts

Bruker Cellular Analysis, Inc. has a source-backed company facts page for reviewing reported financial metrics, periods, and linked metric histories.

Start with the latest metric summary, then open metric histories or cross-company rankings to compare the same SEC-backed facts.

Context
Latest metrics period: Q2 2023
Latest reported value
Return On Equity -87%

Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Open metric pages to inspect the reported history.

Open stable link Open latest 10-Q/10-K hub Which companies report the highest revenue?

Quick Takeaways

  • Bruker Cellular Analysis, Inc. financial facts are built from SEC company filings data.
  • Latest metrics period on this page: Q2 2023.
  • Headline metric: Return On Equity -87%.

What Changed

  • Return On Equity YoY change: <span class="text-green-600">+108%</span>.
  • Most recent SEC facts end date: 31 Jul 2023.

Why This Matters

  • This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
  • Every metric card links to a deeper SEC-backed history page for verification.

Source Evidence

Based on latest 10-Q/10-K

Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Open company facts to inspect the reported metric history.

See Original Filing

Latest SEC snapshot (2023-07-31) highlights Return On Equity -87.2%, Return On Assets -58.3%, and Operating Margin -168.9%.

Compare This Company Through SEC-backed Metrics

Use these links to compare Bruker Cellular Analysis, Inc. against other SEC filers on the same metric, then verify the company history from the paired facts page.

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

33.3/100

Weak Confidence high

Return On Equity

-87%

Metric score 0.0/100

Return On Assets

-58%

Metric score 0.0/100

Financial Health

Current Ratio
2.24x
Quick Ratio
1.07x
Debt to Equity
0.65x

Strengths

Current Ratio, Quick Ratio, and Debt-to-equity

Watchpoints

Return On Equity, Return On Assets, and Operating Margin

Key metrics snapshot

Return On Equity

-87%

YoY: +108%

Industry median: -32% (n=33)

View history

Return On Assets

-58%

YoY: +86%

Industry median: -35% (n=33)

View history

Operating Margin

-169%

YoY: +73%

Industry median: -117% (n=29)

View history

Current Ratio

2.24x

YoY: -66%

Industry median: 2.39x (n=34)

View history

Quick Ratio

1.07x

YoY: -81%

Industry median: 1.25x (n=30)

View history

Debt-to-equity

0.65x

YoY: +69%

Industry median: 0.37x (n=30)

View history

Revenues YoY

-17%

YoY:

Industry median: -0.07% (n=30)

View history

NetIncomeLoss YoY

-46%

YoY:

Industry median: -0.5% (n=31)

View history

Profitability

Metric Latest value YoY change
Return On Equity -87% +108%
Return On Assets -58% +86%
Operating Margin -169% +73%

Financial Health

Metric Latest value YoY change
Current Ratio 2.24x -66%
Quick Ratio 1.07x -81%
Debt-to-equity 0.65x +69%

Growth

Metric Latest value YoY change
Revenues YoY -17%
NetIncomeLoss YoY -46%

Share Metrics

Metric Latest value YoY change
Entity Common Stock, Shares Outstanding 99,296,604 +45%
Common Stock, Shares, Outstanding 99,113,089 +45%
Common Stock, Value, Issued $5,000 +25%
Weighted Average Number of Shares Outstanding, Basic 98,900,780 +45%
Weighted Average Number of Shares Outstanding, Diluted 98,900,780 +45%

Additional Metrics

Metric Latest value YoY change
Revenue from Contract with Customer, Excluding Assessed Tax $71,817,000 -17%
Research and Development Expense $35,219,000 -48%
Operating Income (Loss) $121,271,000 -43%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $124,384,000 -46%
Income Tax Expense (Benefit) $147,000 +1175%
Earnings Per Share, Basic -2 -21%
Earnings Per Share, Diluted -2 -21%
Cash and Cash Equivalents, at Carrying Value $30,964,000 -78%
Cash, Cash Equivalents, and Short-term Investments $31,000,000 -80%
Accounts Receivable, after Allowance for Credit Loss, Current $14,375,000 +4.1%
Inventory, Net $41,455,000 +165%
Other Assets, Current $3,836,000 +19%
Assets, Current $94,786,000 -51%
Property, Plant and Equipment, Net $32,710,000 +12%
Operating Lease, Right-of-Use Asset $26,224,000 +6.9%
Intangible Assets, Net (Excluding Goodwill) $22,499,000
Goodwill $0
Other Assets, Noncurrent $2,020,000 -16%
Assets $178,332,000 -28%
Employee-related Liabilities, Current $6,116,000 -4.4%
Contract with Customer, Liability, Current $9,648,000 +11%
Liabilities, Current $42,225,000 +45%
Contract with Customer, Liability, Noncurrent $876,000 -28%
Operating Lease, Liability, Noncurrent $23,950,000 -0.78%
Liabilities $67,051,000 -9.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax $50,000
Retained Earnings (Accumulated Deficit) $435,312,000 -40%
Stockholders' Equity Attributable to Parent $111,281,000 -36%
Liabilities and Equity $178,332,000 -28%
Common Stock, Shares Authorized 300,000,000 0%
Common Stock, Shares, Issued 99,113,089 +45%
Common Stock, Par or Stated Value Per Share 0 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $31,057,000 -78%
Operating Lease, Liability $28,968,000 +6.6%
Depreciation $9,204,000 +27%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $124,462,000 -46%
Lessee, Operating Lease, Liability, to be Paid $32,991,000 +2.9%
Property, Plant and Equipment, Gross $64,924,000 +18%
Operating Lease, Liability, Current $5,018,000 +65%
Lessee, Operating Lease, Liability, to be Paid, Year Two $5,952,000 +37%
Lessee, Operating Lease, Liability, to be Paid, Year One $6,297,000 +47%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $3,958,000 -18%
Lessee, Operating Lease, Liability, to be Paid, Year Three $5,398,000 +20%
Lessee, Operating Lease, Liability, to be Paid, Year Four $4,759,000 +3%
Additional Paid in Capital $546,538,000 +13%
Amortization of Intangible Assets $577,000
Share-based Payment Arrangement, Expense $18,355,000 -20%
Interest Expense $2,475,000 +171%

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY